Procarbazine (NSC-77213) and multiple myeloma.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D001792:Blood Platelets; D001806:Blood Urea Nitrogen; D001854:Bone Marrow Cells; D005069:Evaluation Studies as Topic; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D011344:Procarbazine / Q000008:administration & dosage / Q000627:therapeutic use; D012712:Serum Globulins / Q000032:analysis
D000970:Antineoplastic Agents; D001565:Benzoates; D006454:Hemoglobins; D012712:Serum Globulins; D011344:Procarbazine